Literature DB >> 446907

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.

R R Holman, R C Turner.   

Abstract

Normal and mildly diabetic subjects each have their own "set" of basal plasma glucose and insulin concentrations. Diabetic patients have raised basal plasma glucose, with low-normal basal plasma C-peptide concentrations. Restoring normal glucose levels in mild diabetes by an insulin infusion further reduces the C-peptide concentration, but both the plasma glucose and the C-peptide return to their "set" level when the insulin is withdrawn. These results accord with the action of beta cells and liver in a negative feedback loop that maintains basal plasma glucose and insulin concentrations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446907     DOI: 10.2337/diab.28.3.227

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  Rethinking the role of the brain in glucose homeostasis and diabetes pathogenesis.

Authors:  Jenny M Brown; Jarrad M Scarlett; Michael W Schwartz
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

2.  Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications.

Authors:  I R Sinay; P Arias; M A Schnitman; S A Damilano; M C Faingold; J A Moguilevsky
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

3.  The Need to Calculate Target Glucose Levels When Measuring Changes in Insulin Sensitivity During Interventions for Individuals With Type 2 Diabetes.

Authors:  Nor Azlan Othman; Paul D Docherty; Jeremy D Krebs; Damon A Bell; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2018-01-02

4.  Nightly amended IRI/BG ratio in fasting test during sleeping periods in subjects with insulinoma and in normal, diabetic and obese subjects.

Authors:  C Villaume; B Beck; J M Dollet; J P Pointel; P Drouin; G Debry
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec

5.  UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year.

Authors: 
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.

Authors:  J C Levy; A Rudenski; M Burnett; R Knight; D R Matthews; R C Turner
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

8.  Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control.

Authors:  J C Daubresse; A Bailly; C Lemy; J C Meunier; A S Luyckx; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1980 Jul-Dec

9.  Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Authors:  J P Hosker; M A Burnett; E G Davies; E A Harris; R C Turner
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

10.  An appreciation of Robert Turner.

Authors:  Stephen O'Rahilly; Gordon C Weir; David R Matthews
Journal:  Diabetes       Date:  2008-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.